ÍøºìºÚÁÏ

Skip to main content
(352) 265-8240

Paul L Crispen, MD : Research

Cancer Specialist (Oncologist), Urologist

Photo of Paul L Crispen
(352) 265-8240 MyUFÍøºìºÚÁÏ

Research at a glance

Top areas of exploration

  • Kidney Neoplasms , 39 publications
  • Carcinoma, Renal Cell , 28 publications
  • Nephrectomy , 20 publications
  • Prostatic Neoplasms , 16 publications

Research activity

95 publications

4,527 citations

Why is this important?

Active clinical trials

Intravesical Gemcitabine and Docetaxel for Low Grade Intermediate Risk Bladder Cancer

Bladder cancer is the 8th most common cancer in the ÍøºìºÚÁÏ Cancer Center catchment area and the 7th most common cancer presenting to UFÍøºìºÚÁÏ. Most newly diagnosed cases are stage I bladder cancer, which is defined by having no deep muscle…

Investigator
Paul L Crispen
Status
Accepting Candidates
Ages
18 Years - N/A
Sexes
All

My publications

95 publications

2013

Editorial comment.

Urology

•

2013

Patterns of care for renal surgery: Underutilization of nephron-sparing procedures.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada

•

2013

Practice-setting and surgeon characteristics heavily influence the decision to perform partial nephrectomy among American Urologic Association surgeons.

BJU international

•

2013

Small renal masses: the effect of illness uncertainty during active surveillance.

Nature reviews. Urology

•

2012

Assessment of the pathologic inclusion criteria from contemporary adjuvant clinical trials for predicting disease progression after nephrectomy for renal cell carcinoma.

Cancer

•